Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| 908 Devices Inc.MASS · Entity 5564 | Director | June 10, 2026 | June 12, 2026 |
| DA32 Life Science Tech Acquisition Corp.DALS · Entity 110669 | Director | July 27, 2021 | July 27, 2021 |
| Quanterix CorpQTRX · Entity 6649 | Director · Executive Chairman | July 05, 2022 | July 06, 2022 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
908 Devices Inc.
Report date June 10, 2026 · Filed June 12, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 165,390 |
Reported balance
After 2026-06-10 transaction · row 1
1 source rowRow 1 · 2026-06-10 · Exercise / conversion · Acquired 14,083 · Balance 165,390 F1: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of Common Stock, par value $0.001, when vested. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2026-06-10 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2026-06-10 · Exercise / conversion · Disposed 14,083 · Balance 0 F1: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of Common Stock, par value $0.001, when vested. F3: The RSUs became fully vested on June 10, 2026, the day prior to the 2026 Annual Meeting of the Stockholders of 908 Devices Inc. The RSUs have no expiration date. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 13,656 |
Reported balance
After 2026-06-11 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2026-06-11 · Grant · Acquired 13,656 · Balance 13,656 F1: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of Common Stock, par value $0.001, when vested. F4: The RSUs become fully vested on June 11, 2027 or the day prior to the 2027 Annual Meeting of the Stockholders of 908 Devices Inc., whichever occurs first, subject to the reporting person's continued service through the applicable vesting date, provided that, if the reporting person terminates their service for any reason, then a prorated number of RSUs will vest. The RSUs have no expiration date. |
| Stock Option (option to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $8.22 · Expires 2036-06-10 | Direct | 6,209 |
Reported balance
After 2026-06-11 transaction · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · 2026-06-11 · Grant · Acquired 6,209 · Balance 6,209 F5: The shares underlying the option become vested and exercisable in substantially equal monthly installments over the 12 months following June 11, 2026, subject to the reporting person's continued service through the applicable vesting date. |
| Common StockSEC Table I · non-derivative | IndirectSee footnote | 329,675 |
Reported balance
Holding disclosure · report date 2026-06-10 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 329,675 F2: The securities are owned directly by the E. Kevin Hrusovsky 2012 Irrevocable Trust. The reporting person's spouse and children are trustees of E. Kevin Hrusovsky 2012 Irrevocable Trust and have joint voting and dispositive control with respect to all securities held by E. Kevin Hrusovsky 2012 Irrevocable Trust and the reporting person may be deemed to be the beneficial owner of the securities held by E. Kevin Hrusovsky 2012 Irrevocable Trust. |
Filing footnotes · ownership attribution and instrument terms
F1: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of Common Stock, par value $0.001, when vested.
F2: The securities are owned directly by the E. Kevin Hrusovsky 2012 Irrevocable Trust. The reporting person's spouse and children are trustees of E. Kevin Hrusovsky 2012 Irrevocable Trust and have joint voting and dispositive control with respect to all securities held by E. Kevin Hrusovsky 2012 Irrevocable Trust and the reporting person may be deemed to be the beneficial owner of the securities held by E. Kevin Hrusovsky 2012 Irrevocable Trust.
F3: The RSUs became fully vested on June 10, 2026, the day prior to the 2026 Annual Meeting of the Stockholders of 908 Devices Inc. The RSUs have no expiration date.
F4: The RSUs become fully vested on June 11, 2027 or the day prior to the 2027 Annual Meeting of the Stockholders of 908 Devices Inc., whichever occurs first, subject to the reporting person's continued service through the applicable vesting date, provided that, if the reporting person terminates their service for any reason, then a prorated number of RSUs will vest. The RSUs have no expiration date.
F5: The shares underlying the option become vested and exercisable in substantially equal monthly installments over the 12 months following June 11, 2026, subject to the reporting person's continued service through the applicable vesting date.
DA32 Life Science Tech Acquisition Corp.
Report date July 27, 2021 · Filed July 27, 2021
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class B Common StockSEC Table II · derivative / convertible security | Direct | Not disclosed |
Reported balance
Holding disclosure · report date 2021-07-27 · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · Balance Not disclosed F1: The reporting person owns 30,000 shares of Class B Common Stock which are convertible into shares of Class A Common Stock as described under the heading "Description of Securities" in the Issuer's registration statement on Form S-1 (File No. 333-257679) and have no expiration date. |
Filing footnotes · ownership attribution and instrument terms
F1: The reporting person owns 30,000 shares of Class B Common Stock which are convertible into shares of Class A Common Stock as described under the heading "Description of Securities" in the Issuer's registration statement on Form S-1 (File No. 333-257679) and have no expiration date.
Quanterix Corp
Report date July 05, 2022 · Filed July 06, 2022
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 910,249 |
Reported balance
After 2022-07-05 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2022-07-05 · Sale · Disposed 960 · Balance 910,249 F1: The sales of shares reported on this Form 4 were made solely to cover tax obligations upon the vesting of 2,068 RSUs. F2: This transaction was executed in multiple trades at prices ranging from $16.18 to $17.10. The price reported reflects the weighted average sale price. The reporting person undertakes to provide upon request to the SEC staff, the issuer or any security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F3: Includes 58,604 restricted stock units and 39,815 shares of common stock subject to performance based vesting. |
Filing footnotes · ownership attribution and instrument terms
F1: The sales of shares reported on this Form 4 were made solely to cover tax obligations upon the vesting of 2,068 RSUs.
F2: This transaction was executed in multiple trades at prices ranging from $16.18 to $17.10. The price reported reflects the weighted average sale price. The reporting person undertakes to provide upon request to the SEC staff, the issuer or any security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F3: Includes 58,604 restricted stock units and 39,815 shares of common stock subject to performance based vesting.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 19, 2021 Filed Feb 22, 2021 16:34 UTC | Quanterix Corp QTRX · Entity 6649 | SaleCommon Stock | 909 | $89.50 | $81,354.86 |
DisclosureSEC source: 0001562180-21-001362 · primarydocument.xml · nonDerivative · entry 4 HRUSOVSKY E KEVIN · CIK 0001252546 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,004,436 F4 · shares: The sales of shares reported on this Form 4 were made solely to cover tax obligations upon the vesting of 9,749 RSUs. F7 · price: This transaction was executed in multiple trades at prices ranging from $89.01 to $89.98. The price reported reflects the weighted average sale price. The reporting person undertakes to provide upon request to the SEC staff, the issuer or any security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F6 · balance_after: Includes 136,919 restricted stock units and 39,815 shares of common stock that are subject to performance based vesting. Read SEC document |
| February 19, 2021 Filed Feb 22, 2021 16:34 UTC | Quanterix Corp QTRX · Entity 6649 | SaleCommon Stock | 591 | $88.67 | $52,403.32 |
DisclosureSEC source: 0001562180-21-001362 · primarydocument.xml · nonDerivative · entry 3 HRUSOVSKY E KEVIN · CIK 0001252546 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,005,345 F4 · shares: The sales of shares reported on this Form 4 were made solely to cover tax obligations upon the vesting of 9,749 RSUs. F5 · price: This transaction was executed in multiple trades at prices ranging from $87.99 to $88.93. The price reported reflects the weighted average sale price. The reporting person undertakes to provide upon request to the SEC staff, the issuer or any security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F6 · balance_after: Includes 136,919 restricted stock units and 39,815 shares of common stock that are subject to performance based vesting. Read SEC document |
| February 18, 2021 Filed Feb 22, 2021 16:34 UTC | Quanterix Corp QTRX · Entity 6649 | SaleCommon Stock | 10 | $85.35 | $853.50 |
DisclosureSEC source: 0001562180-21-001362 · primarydocument.xml · nonDerivative · entry 2 HRUSOVSKY E KEVIN · CIK 0001252546 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,005,936 F1 · kind: The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted on December 14, 2020. F3 · balance_after: Includes 146,668 restricted stock units and 39,815 shares of common stock that are subject to performance based vesting. Read SEC document |
| February 18, 2021 Filed Feb 22, 2021 16:34 UTC | Quanterix Corp QTRX · Entity 6649 | SaleCommon Stock | 4,990 | $83.64 | $417,375.58 |
DisclosureSEC source: 0001562180-21-001362 · primarydocument.xml · nonDerivative · entry 1 HRUSOVSKY E KEVIN · CIK 0001252546 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,005,946 F1 · kind: The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted on December 14, 2020. F2 · price: This transaction was executed in multiple trades at prices ranging from $83.03 to $83.86. The price reported reflects the weighted average sale price. The reporting person undertakes to provide upon request to the SEC staff, the issuer or any security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F3 · balance_after: Includes 146,668 restricted stock units and 39,815 shares of common stock that are subject to performance based vesting. Read SEC document |
| February 09, 2021 Filed Feb 10, 2021 16:11 UTC | Quanterix Corp QTRX · Entity 6649 | SaleCommon Stock | 1,200 | $78.81 | $94,569.48 |
DisclosureSEC source: 0001562180-21-001038 · primarydocument.xml · nonDerivative · entry 4 HRUSOVSKY E KEVIN · CIK 0001252546 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,010,936 F3 · kind: The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted on December 14, 2020. F6 · price: This transaction was executed in multiple trades at prices ranging from $78.64 to $79.16. The price reported reflects the weighted average sale price. The reporting person undertakes to provide upon request to the SEC staff, the issuer or any security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F2 · balance_after: Includes 146,668 restricted stock units and 39,815 shares of common stock that are subject to performance based vesting. Read SEC document |
| February 09, 2021 Filed Feb 10, 2021 16:11 UTC | Quanterix Corp QTRX · Entity 6649 | SaleCommon Stock | 3,100 | $78.24 | $242,552.06 |
DisclosureSEC source: 0001562180-21-001038 · primarydocument.xml · nonDerivative · entry 3 HRUSOVSKY E KEVIN · CIK 0001252546 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,012,136 F3 · kind: The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted on December 14, 2020. F5 · price: This transaction was executed in multiple trades at prices ranging from $77.57 to $78.55. The price reported reflects the weighted average sale price. The reporting person undertakes to provide upon request to the SEC staff, the issuer or any security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F2 · balance_after: Includes 146,668 restricted stock units and 39,815 shares of common stock that are subject to performance based vesting. Read SEC document |
| February 09, 2021 Filed Feb 10, 2021 16:11 UTC | Quanterix Corp QTRX · Entity 6649 | SaleCommon Stock | 700 | $76.81 | $53,765.39 |
DisclosureSEC source: 0001562180-21-001038 · primarydocument.xml · nonDerivative · entry 2 HRUSOVSKY E KEVIN · CIK 0001252546 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,015,236 F3 · kind: The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted on December 14, 2020. F4 · price: This transaction was executed in multiple trades at prices ranging from $76.53 to $77.30. The price reported reflects the weighted average sale price. The reporting person undertakes to provide upon request to the SEC staff, the issuer or any security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F2 · balance_after: Includes 146,668 restricted stock units and 39,815 shares of common stock that are subject to performance based vesting. Read SEC document |
| February 08, 2021 Filed Feb 10, 2021 16:11 UTC | Quanterix Corp QTRX · Entity 6649 | GrantStock Option (right to buy) · Derivative | 42,925 | $0.00 Strike: $77.79 | $0.00 |
DisclosureSEC source: 0001562180-21-001038 · primarydocument.xml · derivative · entry 5 HRUSOVSKY E KEVIN · CIK 0001252546 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,925 Underlying: Common Stock · 42,925 shares Expires 2031-02-08 F7 · derivative.exercise_date: The option vests as to 25% of the shares on February 8, 2022, and the remaining 75% vests in 36 equal monthly installments at the end of each month beginning on February 28, 2022. Read SEC document |
| February 08, 2021 Filed Feb 10, 2021 16:11 UTC | Quanterix Corp QTRX · Entity 6649 | GrantCommon Stock | 18,397 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-21-001038 · primarydocument.xml · nonDerivative · entry 1 HRUSOVSKY E KEVIN · CIK 0001252546 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,015,936 F1 · shares: Represents shares of stock issuable on vesting of restricted stock units. The restricted stock units vest as to 25% of the shares on February 8, 2022, and the remaining 75% vest in 36 equal monthly installments at the end of each month beginning on February 28, 2022. F2 · balance_after: Includes 146,668 restricted stock units and 39,815 shares of common stock that are subject to performance based vesting. Read SEC document |
| February 01, 2021 Filed Feb 2, 2021 20:12 UTC | Quanterix Corp QTRX · Entity 6649 | SaleCommon Stock | 600 | $66.51 | $39,907.98 |
DisclosureSEC source: 0001562180-21-000756 · primarydocument.xml · nonDerivative · entry 5 HRUSOVSKY E KEVIN · CIK 0001252546 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 997,539 F5 · kind: The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted on December 14, 2020. F8 · price: This transaction was executed in multiple trades at prices ranging from $66.49 to $66.58. The price reported reflects the weighted average sale price. The reporting person undertakes to provide upon request to the SEC staff, the issuer or any security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F3 · balance_after: Includes 128,271 restricted stock units and 39,815 shares of common stock that are subject to performance based vesting. Read SEC document |
| February 01, 2021 Filed Feb 2, 2021 20:12 UTC | Quanterix Corp QTRX · Entity 6649 | SaleCommon Stock | 3,700 | $65.90 | $243,821.86 |
DisclosureSEC source: 0001562180-21-000756 · primarydocument.xml · nonDerivative · entry 4 HRUSOVSKY E KEVIN · CIK 0001252546 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 998,139 F5 · kind: The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted on December 14, 2020. F7 · price: This transaction was executed in multiple trades at prices ranging from $65.49 to $66.32. The price reported reflects the weighted average sale price. The reporting person undertakes to provide upon request to the SEC staff, the issuer or any security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F3 · balance_after: Includes 128,271 restricted stock units and 39,815 shares of common stock that are subject to performance based vesting. Read SEC document |
| February 01, 2021 Filed Feb 2, 2021 20:12 UTC | Quanterix Corp QTRX · Entity 6649 | SaleCommon Stock | 700 | $64.70 | $45,291.05 |
DisclosureSEC source: 0001562180-21-000756 · primarydocument.xml · nonDerivative · entry 3 HRUSOVSKY E KEVIN · CIK 0001252546 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,001,839 F5 · kind: The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted on December 14, 2020. F6 · price: This transaction was executed in multiple trades at prices ranging from $64.22 to $64.96. The price reported reflects the weighted average sale price. The reporting person undertakes to provide upon request to the SEC staff, the issuer or any security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F3 · balance_after: Includes 128,271 restricted stock units and 39,815 shares of common stock that are subject to performance based vesting. Read SEC document |
| February 01, 2021 Filed Feb 2, 2021 20:12 UTC | Quanterix Corp QTRX · Entity 6649 | SaleCommon Stock | 1,890 | $68.49 | $129,450.83 |
DisclosureSEC source: 0001562180-21-000756 · primarydocument.xml · nonDerivative · entry 2 HRUSOVSKY E KEVIN · CIK 0001252546 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,002,539 F1 · shares: The sales of shares reported on this Form 4 were made solely to cover tax obligations upon the vesting of 7,123 RSUs. F4 · price: This transaction was executed in multiple trades at prices ranging from $68.27 to $68.63. The price reported reflects the weighted average sale price. The reporting person undertakes to provide upon request to the SEC staff, the issuer or any security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F3 · balance_after: Includes 128,271 restricted stock units and 39,815 shares of common stock that are subject to performance based vesting. Read SEC document |
| February 01, 2021 Filed Feb 2, 2021 20:12 UTC | Quanterix Corp QTRX · Entity 6649 | SaleCommon Stock | 1,359 | $67.93 | $92,316.60 |
DisclosureSEC source: 0001562180-21-000756 · primarydocument.xml · nonDerivative · entry 1 HRUSOVSKY E KEVIN · CIK 0001252546 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,004,429 F1 · shares: The sales of shares reported on this Form 4 were made solely to cover tax obligations upon the vesting of 7,123 RSUs. F2 · price: This transaction was executed in multiple trades at prices ranging from $67.25 to $68.23. The price reported reflects the weighted average sale price. The reporting person undertakes to provide upon request to the SEC staff, the issuer or any security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F3 · balance_after: Includes 128,271 restricted stock units and 39,815 shares of common stock that are subject to performance based vesting. Read SEC document |
| January 25, 2021 Filed Jan 25, 2021 16:01 UTC | Quanterix Corp QTRX · Entity 6649 | SaleCommon Stock | 1,500 | $78.21 | $117,314.10 |
DisclosureSEC source: 0001562180-21-000502 · primarydocument.xml · nonDerivative · entry 2 HRUSOVSKY E KEVIN · CIK 0001252546 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,005,788 F1 · kind: The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted on December 14, 2020. F4 · price: This transaction was executed in multiple trades at prices ranging from $78.06 to $78.33. The price reported reflects the weighted average sale price. The reporting person undertakes to provide upon request to the SEC staff, the issuer or any security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F3 · balance_after: Includes 135,394 restricted stock units and 39,815 shares of common stock that are subject to performance based vesting. Read SEC document |
| January 25, 2021 Filed Jan 25, 2021 16:01 UTC | Quanterix Corp QTRX · Entity 6649 | SaleCommon Stock | 3,500 | $77.64 | $271,741.75 |
DisclosureSEC source: 0001562180-21-000502 · primarydocument.xml · nonDerivative · entry 1 HRUSOVSKY E KEVIN · CIK 0001252546 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,007,288 F1 · kind: The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted on December 14, 2020. F2 · price: This transaction was executed in multiple trades at prices ranging from $77.06 to $78.02. The price reported reflects the weighted average sale price. The reporting person undertakes to provide upon request to the SEC staff, the issuer or any security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F3 · balance_after: Includes 135,394 restricted stock units and 39,815 shares of common stock that are subject to performance based vesting. Read SEC document |
| January 19, 2021 Filed Jan 21, 2021 19:55 UTC | Quanterix Corp QTRX · Entity 6649 | SaleCommon Stock | 1,000 | $76.36 | $76,361.00 |
DisclosureSEC source: 0001562180-21-000446 · primarydocument.xml · nonDerivative · entry 3 HRUSOVSKY E KEVIN · CIK 0001252546 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,010,788 F1 · kind: The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted on December 14, 2020. F5 · price: This transaction was executed in multiple trades at prices ranging from $76.11 to $76.68. The price reported reflects the weighted average sale price. The reporting person undertakes to provide upon request to the SEC staff, the issuer or any security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F3 · balance_after: Includes 135,394 restricted stock units and 39,815 shares of common stock that are subject to performance based vesting. Read SEC document |
| January 19, 2021 Filed Jan 21, 2021 19:55 UTC | Quanterix Corp QTRX · Entity 6649 | SaleCommon Stock | 950 | $75.08 | $71,322.49 |
DisclosureSEC source: 0001562180-21-000446 · primarydocument.xml · nonDerivative · entry 2 HRUSOVSKY E KEVIN · CIK 0001252546 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,011,788 F1 · kind: The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted on December 14, 2020. F4 · price: This transaction was executed in multiple trades at prices ranging from $74.53 to $75.35. The price reported reflects the weighted average sale price. The reporting person undertakes to provide upon request to the SEC staff, the issuer or any security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F3 · balance_after: Includes 135,394 restricted stock units and 39,815 shares of common stock that are subject to performance based vesting. Read SEC document |
| January 19, 2021 Filed Jan 21, 2021 19:55 UTC | Quanterix Corp QTRX · Entity 6649 | SaleCommon Stock | 3,050 | $73.76 | $224,962.82 |
DisclosureSEC source: 0001562180-21-000446 · primarydocument.xml · nonDerivative · entry 1 HRUSOVSKY E KEVIN · CIK 0001252546 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,012,738 F1 · kind: The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted on December 14, 2020. F2 · price: This transaction was executed in multiple trades at prices ranging from $73.47 to $74.30. The price reported reflects the weighted average sale price. The reporting person undertakes to provide upon request to the SEC staff, the issuer or any security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F3 · balance_after: Includes 135,394 restricted stock units and 39,815 shares of common stock that are subject to performance based vesting. Read SEC document |
| January 05, 2021 Filed Jan 6, 2021 16:21 UTC | Quanterix Corp QTRX · Entity 6649 | SaleCommon Stock | 3,510 | $44.13 | $154,902.27 |
DisclosureSEC source: 0001562180-21-000186 · primarydocument.xml · nonDerivative · entry 1 HRUSOVSKY E KEVIN · CIK 0001252546 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,015,788 F1 · shares: The sales of shares reported on this Form 4 were made solely to cover tax obligations upon the vesting of 7,123 RSUs. F2 · price: This transaction was executed in multiple trades at prices ranging from $43.91 to $44.62. The price reported reflects the weighted average sale price. The reporting person undertakes to provide upon request to the SEC staff, the issuer or any security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F3 · balance_after: Includes 135,394 restricted stock units and 39,815 shares of common stock that are subject to performance based vesting. Read SEC document |
| December 22, 2020 Filed Dec 22, 2020 20:40 UTC | 908 Devices Inc. MASS · Entity 5564 | ConversionSeries B Preferred Stock · Derivative | 136,499 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-20-138759 · tm2039218d11.xml · derivative · entry 6 HRUSOVSKY E KEVIN · CIK 0001252546 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 0 Underlying: Common Stock, par value $0.001 · 136,499 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each share of Series A Preferred Stock and Series B Preferred Stock (collectively, the "Preferred Shares") converted into 0.61459 shares of the Issuer's Common Stock automatically upon the closing of the Issuer's initial public offering without payment of additional consideration. The Preferred Shares were convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering, and had no expiration date. F1 · derivative.exercise_date: Each share of Series A Preferred Stock and Series B Preferred Stock (collectively, the "Preferred Shares") converted into 0.61459 shares of the Issuer's Common Stock automatically upon the closing of the Issuer's initial public offering without payment of additional consideration. The Preferred Shares were convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering, and had no expiration date. F1 · derivative.expiration_date: Each share of Series A Preferred Stock and Series B Preferred Stock (collectively, the "Preferred Shares") converted into 0.61459 shares of the Issuer's Common Stock automatically upon the closing of the Issuer's initial public offering without payment of additional consideration. The Preferred Shares were convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering, and had no expiration date. F2 · ownership.nature: The securities are owned directly by the E. Kevin Hrusovsky 2012 Irrevocable Trust. The reporting person's spouse and children are trustees of E. Kevin Hrusovsky 2012 Irrevocable Trust and have joint voting and dispositive control with respect to all securities held by E. Kevin Hrusovsky 2012 Irrevocable Trust and the reporting person may be deemed to be the beneficial owner of the securities held by E. Kevin Hrusovsky 2012 Irrevocable Trust. Read SEC document |
| December 22, 2020 Filed Dec 22, 2020 20:40 UTC | 908 Devices Inc. MASS · Entity 5564 | ConversionSeries B Preferred Stock · Derivative | 33,998 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-20-138759 · tm2039218d11.xml · derivative · entry 5 HRUSOVSKY E KEVIN · CIK 0001252546 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock, par value $0.001 · 33,998 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each share of Series A Preferred Stock and Series B Preferred Stock (collectively, the "Preferred Shares") converted into 0.61459 shares of the Issuer's Common Stock automatically upon the closing of the Issuer's initial public offering without payment of additional consideration. The Preferred Shares were convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering, and had no expiration date. F1 · derivative.exercise_date: Each share of Series A Preferred Stock and Series B Preferred Stock (collectively, the "Preferred Shares") converted into 0.61459 shares of the Issuer's Common Stock automatically upon the closing of the Issuer's initial public offering without payment of additional consideration. The Preferred Shares were convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering, and had no expiration date. F1 · derivative.expiration_date: Each share of Series A Preferred Stock and Series B Preferred Stock (collectively, the "Preferred Shares") converted into 0.61459 shares of the Issuer's Common Stock automatically upon the closing of the Issuer's initial public offering without payment of additional consideration. The Preferred Shares were convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering, and had no expiration date. Read SEC document |
| December 22, 2020 Filed Dec 22, 2020 20:40 UTC | 908 Devices Inc. MASS · Entity 5564 | ConversionSeries A Preferred Stock · Derivative | 101,407 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-20-138759 · tm2039218d11.xml · derivative · entry 4 HRUSOVSKY E KEVIN · CIK 0001252546 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock, par value $0.001 · 101,407 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each share of Series A Preferred Stock and Series B Preferred Stock (collectively, the "Preferred Shares") converted into 0.61459 shares of the Issuer's Common Stock automatically upon the closing of the Issuer's initial public offering without payment of additional consideration. The Preferred Shares were convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering, and had no expiration date. F1 · derivative.exercise_date: Each share of Series A Preferred Stock and Series B Preferred Stock (collectively, the "Preferred Shares") converted into 0.61459 shares of the Issuer's Common Stock automatically upon the closing of the Issuer's initial public offering without payment of additional consideration. The Preferred Shares were convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering, and had no expiration date. F1 · derivative.expiration_date: Each share of Series A Preferred Stock and Series B Preferred Stock (collectively, the "Preferred Shares") converted into 0.61459 shares of the Issuer's Common Stock automatically upon the closing of the Issuer's initial public offering without payment of additional consideration. The Preferred Shares were convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering, and had no expiration date. Read SEC document |
| December 22, 2020 Filed Dec 22, 2020 20:40 UTC | 908 Devices Inc. MASS · Entity 5564 | ConversionCommon Stock, par value $0.001 | 136,499 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001104659-20-138759 · tm2039218d11.xml · nonDerivative · entry 3 HRUSOVSKY E KEVIN · CIK 0001252546 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 136,499 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each share of Series A Preferred Stock and Series B Preferred Stock (collectively, the "Preferred Shares") converted into 0.61459 shares of the Issuer's Common Stock automatically upon the closing of the Issuer's initial public offering without payment of additional consideration. The Preferred Shares were convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering, and had no expiration date. F2 · ownership.nature: The securities are owned directly by the E. Kevin Hrusovsky 2012 Irrevocable Trust. The reporting person's spouse and children are trustees of E. Kevin Hrusovsky 2012 Irrevocable Trust and have joint voting and dispositive control with respect to all securities held by E. Kevin Hrusovsky 2012 Irrevocable Trust and the reporting person may be deemed to be the beneficial owner of the securities held by E. Kevin Hrusovsky 2012 Irrevocable Trust. Read SEC document |
| December 22, 2020 Filed Dec 22, 2020 20:40 UTC | 908 Devices Inc. MASS · Entity 5564 | PurchaseCommon Stock, par value $0.001 | 50,000 | $20.00 | $1,000,000.00 |
DisclosureSEC source: 0001104659-20-138759 · tm2039218d11.xml · nonDerivative · entry 2 HRUSOVSKY E KEVIN · CIK 0001252546 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 243,176 Read SEC document |
| December 22, 2020 Filed Dec 22, 2020 20:40 UTC | 908 Devices Inc. MASS · Entity 5564 | ConversionCommon Stock, par value $0.001 | 135,405 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001104659-20-138759 · tm2039218d11.xml · nonDerivative · entry 1 HRUSOVSKY E KEVIN · CIK 0001252546 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 193,176 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each share of Series A Preferred Stock and Series B Preferred Stock (collectively, the "Preferred Shares") converted into 0.61459 shares of the Issuer's Common Stock automatically upon the closing of the Issuer's initial public offering without payment of additional consideration. The Preferred Shares were convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering, and had no expiration date. Read SEC document |
| December 08, 2020 Filed Dec 10, 2020 17:48 UTC | Quanterix Corp QTRX · Entity 6649 | SaleCommon Stock | 2,000 | $46.98 | $93,960.00 |
DisclosureSEC source: 0001562180-20-007177 · primarydocument.xml · nonDerivative · entry 1 HRUSOVSKY E KEVIN · CIK 0001252546 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,019,298 F1 · shares: The sales of shares was effected pursuant to a 10b5-1 trading plan adopted on December 5, 2019. F2 · balance_after: Includes 142,517 restricted stock units and 39,815 shares of common stock that are subject to performance based vesting. Read SEC document |
| December 01, 2020 Filed Dec 3, 2020 16:40 UTC | Quanterix Corp QTRX · Entity 6649 | SaleCommon Stock | 1,728 | $44.13 | $76,263.72 |
DisclosureSEC source: 0001562180-20-007044 · primarydocument.xml · nonDerivative · entry 2 HRUSOVSKY E KEVIN · CIK 0001252546 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,021,298 F1 · shares: The sales of shares reported on this Form 4 were made solely to cover tax obligations upon the vesting of 7,123 RSUs. F3 · price: This transaction was executed in multiple trades at prices ranging from $44.01 to $44.39. The price reported reflects the weighted average sale price. The reporting person undertakes to provide upon request to the SEC staff, the issuer or any security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F4 · balance_after: Includes 142,517 restricted stock units and 39,815 shares of common stock that are subject to performance based vesting. Read SEC document |
| December 01, 2020 Filed Dec 3, 2020 16:40 UTC | Quanterix Corp QTRX · Entity 6649 | SaleCommon Stock | 1,508 | $43.31 | $65,305.15 |
DisclosureSEC source: 0001562180-20-007044 · primarydocument.xml · nonDerivative · entry 1 HRUSOVSKY E KEVIN · CIK 0001252546 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,023,026 F1 · shares: The sales of shares reported on this Form 4 were made solely to cover tax obligations upon the vesting of 7,123 RSUs. F2 · price: This transaction was executed in multiple trades at prices ranging from $43.00 to $43.94. The price reported reflects the weighted average sale price. The reporting person undertakes to provide upon request to the SEC staff, the issuer or any security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| November 19, 2020 Filed Nov 20, 2020 16:19 UTC | Quanterix Corp QTRX · Entity 6649 | SaleCommon Stock | 2,000 | $44.25 | $88,500.00 |
DisclosureSEC source: 0001562180-20-006819 · primarydocument.xml · nonDerivative · entry 1 HRUSOVSKY E KEVIN · CIK 0001252546 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,024,534 F1 · shares: The sales of shares was effected pursuant to a 10b5-1 trading plan adopted on December 5, 2019. F2 · balance_after: Includes 149,640 restricted stock units and 39,815 shares of common stock that are subject to performance based vesting. Read SEC document |
| November 12, 2020 Filed Nov 16, 2020 16:51 UTC | Quanterix Corp QTRX · Entity 6649 | SaleCommon Stock | 2,000 | $49.39 | $98,780.00 |
DisclosureSEC source: 0001562180-20-006715 · primarydocument.xml · nonDerivative · entry 1 HRUSOVSKY E KEVIN · CIK 0001252546 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,026,534 F1 · shares: The sales of shares was effected pursuant to a 10b5-1 trading plan adopted on December 5, 2019. F2 · balance_after: Includes 149,640 restricted stock units and 39,815 shares of common stock that are subject to performance based vesting. Read SEC document |
| November 02, 2020 Filed Nov 3, 2020 16:05 UTC | Quanterix Corp QTRX · Entity 6649 | SaleCommon Stock | 3,264 | $36.97 | $120,665.84 |
DisclosureSEC source: 0001562180-20-006518 · primarydocument.xml · nonDerivative · entry 2 HRUSOVSKY E KEVIN · CIK 0001252546 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,028,534 F3 · shares: The sales of shares reported on this Form 4 were made solely to cover tax obligations upon the vesting of 7,123 RSUs. F4 · price: This transaction was executed in multiple trades at prices ranging from $36.52 to $37.33. The price reported reflects the weighted average sale price. The reporting person undertakes to provide upon request to the SEC staff, the issuer or any security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F5 · balance_after: Includes 149,640 restricted stock units and 39,815 shares of common stock that are subject to performance based vesting. Read SEC document |
| October 29, 2020 Filed Nov 3, 2020 16:05 UTC | Quanterix Corp QTRX · Entity 6649 | SaleCommon Stock | 2,000 | $38.30 | $76,600.00 |
DisclosureSEC source: 0001562180-20-006518 · primarydocument.xml · nonDerivative · entry 1 HRUSOVSKY E KEVIN · CIK 0001252546 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,031,798 F1 · shares: The sales of shares was effected pursuant to a 10b5-1 trading plan adopted on December 5, 2019. F2 · balance_after: Includes 156,763 restricted stock units and 39,815 shares of common stock that are subject to performance based vesting. Read SEC document |
| October 13, 2020 Filed Oct 15, 2020 17:36 UTC | Quanterix Corp QTRX · Entity 6649 | SaleCommon Stock | 2,000 | $44.49 | $88,980.00 |
DisclosureSEC source: 0001562180-20-006370 · primarydocument.xml · nonDerivative · entry 1 HRUSOVSKY E KEVIN · CIK 0001252546 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,033,798 F1 · shares: The sales of shares was effected pursuant to a 10b5-1 trading plan adopted on December 5, 2019. F2 · balance_after: Includes 156,763 restricted stock units and 39,815 shares of common stock that are subject to performance based vesting. Read SEC document |
| October 05, 2020 Filed Oct 5, 2020 17:29 UTC | Quanterix Corp QTRX · Entity 6649 | SaleCommon Stock | 2,000 | $33.90 | $67,800.00 |
DisclosureSEC source: 0001562180-20-006294 · primarydocument.xml · nonDerivative · entry 1 HRUSOVSKY E KEVIN · CIK 0001252546 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,035,798 F1 · shares: The sales of shares was effected pursuant to a 10b5-1 trading plan adopted on December 5, 2019. F2 · balance_after: Includes 156,763 restricted stock units and 39,815 shares of common stock that are subject to performance based vesting. Read SEC document |
| October 01, 2020 Filed Oct 2, 2020 16:00 UTC | Quanterix Corp QTRX · Entity 6649 | SaleCommon Stock | 3,286 | $34.12 | $112,126.21 |
DisclosureSEC source: 0001562180-20-006209 · primarydocument.xml · nonDerivative · entry 1 HRUSOVSKY E KEVIN · CIK 0001252546 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,037,798 F1 · shares: The sales of shares reported on this Form 4 were made solely to cover tax obligations upon the vesting of 7,123 RSUs. F2 · price: This transaction was executed in multiple trades at prices ranging from $33.881 to $34.51. The price reported reflects the weighted average sale price. The reporting person undertakes to provide upon request to the SEC staff, the issuer or any security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F3 · balance_after: Includes 156,763 restricted stock units and 39,815 shares of common stock that are subject to performance based vesting. Read SEC document |
| September 24, 2020 Filed Sep 29, 2020 16:53 UTC | Quanterix Corp QTRX · Entity 6649 | SaleCommon Stock | 2,000 | $32.26 | $64,520.00 |
DisclosureSEC source: 0001562180-20-006126 · primarydocument.xml · nonDerivative · entry 1 HRUSOVSKY E KEVIN · CIK 0001252546 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,041,084 F1 · shares: The sales of shares was effected pursuant to a 10b5-1 trading plan adopted on December 5, 2019. F2 · balance_after: Includes 163,886 restricted stock units and 39,815 shares of common stock that are subject to performance based vesting. Read SEC document |
| September 15, 2020 Filed Sep 16, 2020 16:08 UTC | Quanterix Corp QTRX · Entity 6649 | SaleCommon Stock | 3,500 | $33.15 | $116,037.25 |
DisclosureSEC source: 0001562180-20-006003 · primarydocument.xml · nonDerivative · entry 1 HRUSOVSKY E KEVIN · CIK 0001252546 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,043,084 F1 · shares: The sales of shares was effected pursuant to a 10b5-1 trading plan adopted on December 5, 2019. F2 · price: This transaction was executed in multiple trades at prices ranging from $33.08 to $33.24. The price reported reflects the weighted average sale price. The reporting person undertakes to provide upon request to the SEC staff, the issuer or any security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F3 · balance_after: Includes 163,886 restricted stock units and 39,815 shares of common stock that are subject to performance based vesting. Read SEC document |
| September 01, 2020 Filed Sep 3, 2020 19:48 UTC | Quanterix Corp QTRX · Entity 6649 | SaleCommon Stock | 3,390 | $34.91 | $118,348.63 |
DisclosureSEC source: 0001562180-20-005882 · primarydocument.xml · nonDerivative · entry 1 HRUSOVSKY E KEVIN · CIK 0001252546 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,046,584 F1 · shares: The sales of shares reported on this Form 4 were made solely to cover tax obligations upon the vesting of 7,123 RSUs. F2 · price: This transaction was executed in multiple trades at prices ranging from $34.89 to $34.913. The price reported reflects the weighted average sale price. The reporting person undertakes to provide upon request to the SEC staff, the issuer or any security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F3 · balance_after: Includes 163,886 restricted stock units and 39,815 shares of common stock that are subject to performance based vesting. Read SEC document |
| August 25, 2020 Filed Aug 26, 2020 17:09 UTC | Quanterix Corp QTRX · Entity 6649 | SaleCommon Stock | 3,500 | $35.28 | $123,468.45 |
DisclosureSEC source: 0001562180-20-005674 · primarydocument.xml · nonDerivative · entry 1 HRUSOVSKY E KEVIN · CIK 0001252546 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,049,974 F1 · shares: The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted on December 5, 2019. F2 · price: This transaction was executed in multiple trades at prices ranging from $35.00 to $35.715. The price reported reflects the weighted average sale price. The reporting person undertakes to provide upon request to the SEC staff, the issuer or any security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F3 · balance_after: Includes 171,009 restricted stock units and 39,815 shares of common stock that are subject to performance based vesting. Read SEC document |
| August 14, 2020 Filed Aug 14, 2020 17:40 UTC | Quanterix Corp QTRX · Entity 6649 | SaleCommon Stock | 1,500 | $37.05 | $55,570.20 |
DisclosureSEC source: 0001562180-20-005445 · primarydocument.xml · nonDerivative · entry 2 HRUSOVSKY E KEVIN · CIK 0001252546 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,053,474 F1 · shares: The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted on December 5, 2019. F4 · price: This transaction was executed in multiple trades at prices ranging from $37.00 to $37.05. The price reported reflects the weighted average sale price. The reporting person undertakes to provide upon request to the SEC staff, the issuer or any security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F3 · balance_after: Includes 171,009 restricted stock units and 39,815 shares of common stock that are subject to performance based vesting. Read SEC document |
| August 14, 2020 Filed Aug 14, 2020 17:40 UTC | Quanterix Corp QTRX · Entity 6649 | SaleCommon Stock | 2,000 | $36.48 | $72,962.40 |
DisclosureSEC source: 0001562180-20-005445 · primarydocument.xml · nonDerivative · entry 1 HRUSOVSKY E KEVIN · CIK 0001252546 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,054,974 F1 · shares: The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted on December 5, 2019. F2 · price: This transaction was executed in multiple trades at prices ranging from $35.90 to $36.80. The price reported reflects the weighted average sale price. The reporting person undertakes to provide upon request to the SEC staff, the issuer or any security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F3 · balance_after: Includes 171,009 restricted stock units and 39,815 shares of common stock that are subject to performance based vesting. Read SEC document |
| August 04, 2020 Filed Aug 5, 2020 17:14 UTC | Quanterix Corp QTRX · Entity 6649 | SaleCommon Stock | 4,000 | $32.11 | $128,436.80 |
DisclosureSEC source: 0001562180-20-005330 · primarydocument.xml · nonDerivative · entry 3 HRUSOVSKY E KEVIN · CIK 0001252546 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,056,974 F4 · shares: The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted on December 5, 2019. F5 · price: This transaction was executed in multiple trades at prices ranging from $31.66 to $32.45. The price reported reflects the weighted average sale price. The reporting person undertakes to provide upon request to the SEC staff, the issuer or any security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F3 · balance_after: Includes 171,009 restricted stock units and 39,815 shares of common stock that are subject to performance based vesting. Read SEC document |
| August 03, 2020 Filed Aug 5, 2020 17:14 UTC | Quanterix Corp QTRX · Entity 6649 | SaleCommon Stock | 79 | $33.33 | $2,633.07 |
DisclosureSEC source: 0001562180-20-005330 · primarydocument.xml · nonDerivative · entry 2 HRUSOVSKY E KEVIN · CIK 0001252546 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,060,974 F1 · shares: The sales of shares reported on this Form 4 were made solely to cover tax obligations upon the vesting of 7,123 RSUs. F3 · balance_after: Includes 171,009 restricted stock units and 39,815 shares of common stock that are subject to performance based vesting. Read SEC document |
| August 03, 2020 Filed Aug 5, 2020 17:14 UTC | Quanterix Corp QTRX · Entity 6649 | SaleCommon Stock | 3,151 | $32.23 | $101,555.15 |
DisclosureSEC source: 0001562180-20-005330 · primarydocument.xml · nonDerivative · entry 1 HRUSOVSKY E KEVIN · CIK 0001252546 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,061,053 F1 · shares: The sales of shares reported on this Form 4 were made solely to cover tax obligations upon the vesting of 7,123 RSUs. F2 · price: This transaction was executed in multiple trades at prices ranging from $32.2444 to $33.18. The price reported reflects the weighted average sale price. The reporting person undertakes to provide upon request to the SEC staff, the issuer or any security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F3 · balance_after: Includes 171,009 restricted stock units and 39,815 shares of common stock that are subject to performance based vesting. Read SEC document |
| July 21, 2020 Filed Jul 23, 2020 20:38 UTC | Quanterix Corp QTRX · Entity 6649 | SaleCommon Stock | 2,636 | $31.87 | $84,015.65 |
DisclosureSEC source: 0001562180-20-005213 · primarydocument.xml · nonDerivative · entry 1 HRUSOVSKY E KEVIN · CIK 0001252546 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,064,204 F1 · kind: The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted on December 5, 2019. F2 · price: This transaction was executed in multiple trades at prices ranging from $31.85 to $31.98. The price reported reflects the weighted average sale price. The reporting person undertakes to provide upon request to the SEC staff, the issuer or any security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F3 · balance_after: Includes 178,132 restricted stock units and 39,815 shares of common stock that are subject to performance based vesting. Read SEC document |
| July 16, 2020 Filed Jul 17, 2020 18:05 UTC | Quanterix Corp QTRX · Entity 6649 | SaleCommon Stock | 4,500 | $27.94 | $125,730.00 |
DisclosureSEC source: 0001562180-20-005175 · primarydocument.xml · nonDerivative · entry 1 HRUSOVSKY E KEVIN · CIK 0001252546 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,066,840 F1 · kind: The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted on December 5, 2019. F2 · balance_after: Includes 178,132 restricted stock units and 39,815 shares of common stock that are subject to performance based vesting. Read SEC document |
| July 01, 2020 Filed Jul 6, 2020 16:13 UTC | Quanterix Corp QTRX · Entity 6649 | SaleCommon Stock | 237 | $27.45 | $6,505.65 |
DisclosureSEC source: 0001562180-20-004987 · primarydocument.xml · nonDerivative · entry 2 HRUSOVSKY E KEVIN · CIK 0001252546 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,071,340 F1 · shares: The sales of shares reported on this Form 4 were made solely to cover tax obligations upon the vesting of 7,123 RSUs. F4 · price: This transaction was executed in multiple trades at prices ranging from $27.39 to $27.57. The price reported reflects the weighted average sale price. The reporting person undertakes to provide upon request to the SEC staff, the issuer or any security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F3 · balance_after: Includes 178,132 restricted stock units and 39,815 shares of common stock that are subject to performance based vesting. Read SEC document |
| July 01, 2020 Filed Jul 6, 2020 16:13 UTC | Quanterix Corp QTRX · Entity 6649 | SaleCommon Stock | 3,060 | $26.83 | $82,095.21 |
DisclosureSEC source: 0001562180-20-004987 · primarydocument.xml · nonDerivative · entry 1 HRUSOVSKY E KEVIN · CIK 0001252546 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,071,577 F1 · shares: The sales of shares reported on this Form 4 were made solely to cover tax obligations upon the vesting of 7,123 RSUs. F2 · price: This transaction was executed in multiple trades at prices ranging from $26.39 to $27.22. The price reported reflects the weighted average sale price. The reporting person undertakes to provide upon request to the SEC staff, the issuer or any security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F3 · balance_after: Includes 178,132 restricted stock units and 39,815 shares of common stock that are subject to performance based vesting. Read SEC document |
| June 23, 2020 Filed Jun 25, 2020 16:01 UTC | Quanterix Corp QTRX · Entity 6649 | SaleCommon Stock | 5,000 | $27.07 | $135,345.00 |
DisclosureSEC source: 0001562180-20-004685 · primarydocument.xml · nonDerivative · entry 1 HRUSOVSKY E KEVIN · CIK 0001252546 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,074,637 F1 · kind: The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted on December 5, 2019. F2 · price: This transaction was executed in multiple trades at prices ranging from $26.87 to $27.48. The price reported reflects the weighted average sale price. The reporting person undertakes to provide upon request to the SEC staff, the issuer or any security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F3 · balance_after: Includes 185,255 restricted stock units and 39,815 shares of common stock that are subject to performance based vesting. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.